作者
Chenjun Mu,Pan Liu,L Liu,Yaqing Wang,Kefu Liu,Xiangyu Li,Guozhong Li,Jianbo Cheng,M.N. Bu,Jie Chen,Manpei Tang,Yuanhang Yao,Jun Guan,Tiantian Ma,Zhengrong Zhou,Qing-Feng Wu,Jia‐Da Li,Hui Guo,Kun Xia,Zhengmao Hu,Xiaoqing Peng,Bing Lang,Faxiang Li,Xiaowei Chen,Zhiheng Xu,Ling Yuan
摘要
KCTD10, a member of the potassium channel tetramerization domain (KCTD) family, is implicated in neuropsychiatric disorders and functions as a substrate recognition component within the RING-type ubiquitin ligase complex. A rare de novo variant of KCTD10, p.C124W, was identified in schizophrenia cases, yet its underlying pathogenesis remains unexplored. Here, we demonstrate that heterozygous KCTD10 C124W mice display pronounced synaptic abnormalities and exhibit schizophrenia-like behaviors. Mechanistically, we reveal that KCTD10 undergoes liquid–liquid phase separation (LLPS), a process orchestrated by its intrinsically disordered region (IDR). p.C124W mutation disrupts this LLPS capability, leading to diminished degradation of RHOB and subsequent excessive accumulation in the postsynaptic density fractions. Notably, neither IDR deletion nor p.C124W mutation in KCTD10 mitigates the synaptic abnormalities caused by Kctd10 deficiency. Thus, our findings implicate that LLPS may be associated with the pathogenesis of KCTD10-associated brain disorders and highlight the potential of targeting RHOB as a therapeutic strategy for diseases linked to mutations in KCTD10 or RHOB.